BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Maximum tolerated dose (MTD), safety, pharmacokinetic and pharmacodynamic parameters, and
efficacy of pulsatile administration of BIBW 2992 in combination with docetaxel (Taxotere®)